247P Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study

Authors :: Andreas Schneeweiss
Wolfgang Janni
Tanja Fehm
Claudia Quiering
J Kreuzeder
Hans Tesch
Sara Y. Brucker
Mattea Reinisch
S Kümmel
Christian M. Kurbacher
Andreas D. Hartkopf
Thomas Decker
Arnd Nusch
Bernhard Heinrich
Diana Lüftner
Petra Krabisch
R. Fuchs
J Huober
Martin Schuler
Peter A. Fasching
Source :: Annals of Oncology. 32:S467-S468
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Letrozole
Advanced breast
Cancer
Estrogen receptor
Ribociclib
Hematology
medicine.disease
Internal medicine
Medicine
In patient
business
medicine.drug

Full Text Access

Tools